Anteris Technologies Global (ASX:AVR) Earnings Yield (Joel Greenblatt) %: -36.36% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:AVR Anteris Technologies Global Corp ASX:AVR
45 GF Score
Price A$11.37
! 5 Warning Signs
View Full Analysis

What is Anteris Technologies Global Earnings Yield (Joel Greenblatt) %?

Anteris Technologies Global ASX:AVR -3.64% 45 Earnings Yield (Joel Greenblatt) % is -36.36% as of Mar. 2026. GuruFocus rates ASX:AVR with a GF Score™ of 45/100. The stock has 5 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Anteris Technologies Global ranks worse than 80.28% on this metric.

Anteris Technologies Global's Enterprise Value for the quarter that ended in Mar. 2026 was A$312.22 Mil. Anteris Technologies Global's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was A$-141.52 Mil. Anteris Technologies Global's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2026 was -36.36%.

The historical rank and industry rank for Anteris Technologies Global's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

ASX:AVR' s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -371.24   Med: -55.61   Max: -16.57
Current: -19.42

During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Anteris Technologies Global was -16.57%. The lowest was -371.24%. And the median was -55.61%.

ASX:AVR's Earnings Yield (Joel Greenblatt) % is ranked worse than
80.28% of 852 companies
in the Medical Devices & Instruments industry
Industry Median: 0.83 vs ASX:AVR: -19.42

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Anteris Technologies Global's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2026 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


Anteris Technologies Global  (ASX:AVR) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.


Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.


Anteris Technologies Global Earnings Yield (Joel Greenblatt) % Related Terms


Anteris Technologies Global Earnings Yield (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Anteris Technologies Global's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anteris Technologies Global Earnings Yield (Joel Greenblatt) % Chart

Anteris Technologies Global Annual Data
Trend Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Earnings Yield (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -16.95 -14.73 -22.37 -57.80 -47.85

Anteris Technologies Global Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Earnings Yield (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -97.09 -75.76 -54.35 -47.85 -36.36

ASX:AVR vs QDEL, INMD, CNMD: Earnings Yield (Joel Greenblatt) % Comparison

For the Medical Devices subindustry, Anteris Technologies Global's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anteris Technologies Global Earnings Yield (Joel Greenblatt) % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Anteris Technologies Global's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Anteris Technologies Global's Earnings Yield (Joel Greenblatt) % falls into.


ASX:AVR
45GF Score
Anteris Technologies Global Corp ASX:AVR
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anteris Technologies Global Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

Anteris Technologies Globals Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2025 is calculated as

Earnings Yield (Joel Greenblatt)=EBIT/Enterprise Value
=-141.699/302.7698
=-46.80 %

Anteris Technologies Global's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was A$-141.52 Mil.


What does a Earnings Yield (Joel Greenblatt) % of -36.36% mean?
Anteris Technologies Global (ASX:AVR) has a Earnings Yield (Joel Greenblatt) % of -36.36% as of Mar. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Anteris Technologies Global and its competitors. According to the industry distribution chart, Anteris Technologies Global ranks #684 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 80.3%.
Is Anteris Technologies Global's Earnings Yield (Joel Greenblatt) % too high?
Anteris Technologies Global's current Earnings Yield (Joel Greenblatt) % is -36.36%. Based on the distribution chart, Anteris Technologies Global ranks #684 out of 852 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Anteris Technologies Global has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does Anteris Technologies Global's Earnings Yield (Joel Greenblatt) % compare to QDEL and INMD?
According to the Medical Devices & Instruments industry distribution chart, Anteris Technologies Global ranks #684 out of 852 companies for Earnings Yield (Joel Greenblatt) %. This places Anteris Technologies Global in the lower half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 0.83. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median Earnings Yield (Joel Greenblatt) % among Medical Devices & Instruments companies is 0.83, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Anteris Technologies Global and its competitors. For the Medical Devices & Instruments industry, the median Earnings Yield (Joel Greenblatt) % is 0.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Anteris Technologies Global's current Earnings Yield (Joel Greenblatt) % is -36.36%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anteris Technologies Global stock overvalued right now?
Anteris Technologies Global (ASX:AVR) has a current Earnings Yield (Joel Greenblatt) % of -36.36%. The current Earnings Yield (Joel Greenblatt) % is -36.36%. Anteris Technologies Global's overall GF Score™ is 45/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Anteris Technologies Global (ASX:AVR), the current Earnings Yield (Joel Greenblatt) % is -36.36% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anteris Technologies Global Business Description

Other Exchanges AVR:USA
Address 9 Sherwood Road, Level 3, Suite 302, Toowong Tower, Toowong, QLD, AUS, 4066
Anteris Technologies Global Corp is a structural heart company focused on advancing cardiac care through science-driven innovations aimed at restoring heart valve patients to healthy function. Its key product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with interventional cardiologists and cardiac surgeons to treat Aortic Stenosis, a potentially life-threatening condition caused by narrowing of the aortic valve. The balloon-expandable DurAVR THV is a biomimetic valve designed to mimic the performance of a healthy human aortic valve and replicate normal aortic blood flow. The company operates in United States, Germany, Australia, Switzerland, and Sweden, with the majority of its revenue generated from the United States.
45GF Score

Get the complete analysis for ASX:AVR

Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$11.37
Price